- Перевірено
Receptor.ai
IT, 10–50 співробітників
- receptor.ai/
- Alan Nafiiev CEO & Co-founder at Receptor.ai
Receptor.AI is the US biotechnology startup, which utilizes artificial intelligence and machine learning to provide complete pipeline of the rational drug design: from searching for molecular targets to predicting the outcome of clinical trials.
We work at the cutting edge of life sciences and advanced computer technologies, which may radically change our civilization in the near future.
Our team consists of ambitious professionals in bioinformatics, cheminformatics, biophysics, biochemistry, mathematics, big data, machine learning and artificial intelligence.
We are now establishing our company and developing products and services based on artificial intelligence, which we will soon describe in details.